Early Health Technology Assessment Advanced Training

PROGRAMME ELEMENTS

Basics to early phase HTA
1. Rationale of HTA
2. Business model
3. Target product profile
4. Case study Part I. Problem formulation
Strategic pricing
1. Actors of early HTA
2. Strategic pricing
3. Headroom analysis
4. Economic modelling methods
5. Case study Part II: Economic value calculation
6. Case study Part III: Comparison of economic value in different target indications
Net present value calculation and commercialisation plan
1. Principles of Net Present Value calculation
2. Understanding the investor’s perspective
3. Case study Part IV: Net present value calculation of development scenario
4. Case study Part V: Go - no go decision, priority setting of target indications
5. Market entry and commercialisation

8 x 30' webinars in preparation before the online lectures		Lecturer
a. Economic environment for investment to medical technologies and digital health solutions		Jászkuti Bertalan
b. Rationale of early phase health technology assessment		Zoltán Kaló
c. Business model		Zoltán Kaló
d. Target product profile & economic value drivers		Balázs Nagy
e. Principles of strategic pricing		Zoltán Kaló
f. Principles of net present value (NPV) calculation		Mezei Fruzsina
g. Business model of technologies purchased by health care providers		Zoltán Kaló
h. Business model of technologies purchased by patients		Ádám Ildikó

50' online lectures		Lecturer
Day 1
a. Case study (Part 1): Business model of technologies with public reimbursement		Kaló Zoltán
b. Case study (Part 2): Building an economic model for economic value calculation		Kaló Zoltán
c. Case study (Part 3): Comparison of economic value in different target indications		Kaló Zoltán
Day 2
a. Case study (Part 4): Comparison of NPV in different target indications		Kaló Zoltán
b. Case study (Part 5): Go – no go decision, priority setting of target indications		Kaló Zoltán
c. Company valuation, Investors and Exit strategy		Jászkuti Bertalan